Bepranemab, CAS 2244960-75-4

Product Description: Bepranemab (UCB 0107) is a humanized, full-length IgG4 monoclonal antibody that binds to a central tau epitope (amino acids 235-250). Bepranemab can be used for Alzheimer’s disease (AD) research[1].

Applications: Neuroscience-Neurodegeneration

Formula: N/A

References: [1]Matthew E Barton, et al. Design of a patient- and investigator-blind, randomized, placebo-controlled study to evaluate efficacy, safety, and tolerability of bepranemab, UCB0107, in prodromal to mild Alzheimer’s disease: The TOGETHER Study, AH0003. Alzheimer's & Dementia. 31 December 2021.

CAS Number: 2244960-75-4

Molecular Weight: N/A

Compound Purity: 99.79

Research Area: Neurological Disease

Solubility: 10 mM in DMSO

Target: Tau Protein

• Artikelnummer: MEXHY-P99471-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99471-1
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated